Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726985 · ClinicalTrials.gov registry record
Model for Heart Failure ExAcerbation Reduction Trial
A clinical trial, sponsored by Cleveland Clinic Florida.
- Completed
- Registry status
- 230
- Enrollment target
NCT01726985 is a clinical trial that has completed, run by Cleveland Clinic Florida. The registered enrollment target is 230 participants.
The verdict
NCT01726985 has completed, sponsored by Cleveland Clinic Florida.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
Study Summary
Heart failure is the leading cause of hospitalizations and readmissions in the United States and is a tremendous economic strain on our healthcare system. There is currently, based on national averages, a 30% readmission rate and 10% mortality rate within 3 months of being hospitalized for heart failure. Retrospective studies have shown benefit to using biomarkers such as BNP to guide inpatient heart failure management. Our own CCF retrospective study showed that decreasing NT-ProBNP by 23%, making patients fluid negative by more than 1.3L, and discharging patients with serum sodium above 135 reduces readmission rates significantly. The purpose of this study is to prospectively use the above mentioned goals in the treatment of heart failure in order to reduce heart failure readmission and mortality rates.
Interventions
- OTHER Parameter Based Clinical Disposition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01726985
The ClinicalTrials.gov registry entry for NCT01726985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cleveland Clinic Florida, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parameter Based Clinical Disposition is the first listed.
NCT01726985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01726985 about?
NCT01726985 is a clinical study titled "Model for Heart Failure ExAcerbation Reduction Trial". Heart failure is the leading cause of hospitalizations and readmissions in the United States and is a tremendous economic strain on our healthcare system. There is currently, based on national averages, a 30% readmission rate and 10% mortality rate within 3 months of being hospitalized for heart fai...
What is the current status of trial NCT01726985?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2012-11. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01726985?
The interventions under investigation include: Parameter Based Clinical Disposition (OTHER).
Who is sponsoring clinical trial NCT01726985?
This trial is sponsored by Cleveland Clinic Florida, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.